Advertisement
BME vs DHR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BME is a Hold and DHR is a StrongBuy.
BME in upward trend: 10-day moving average crossed above 50-day moving average on October 22, 2026
The 10-day moving average for BME crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BME's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on BME as a result. In 58 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for BME just turned positive on October 14, 2026. Looking at past instances where BME's MACD turned positive, the stock continued to rise in 42 of 53 cases over the following month. The odds of a continued upward trend are 79%.
BME moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where BME advanced for three days, in 272 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BME declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
BME broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BME entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
DHR's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for DHR turned positive on October 14, 2026. Looking at past instances where DHR's MACD turned positive, the stock continued to rise in 31 of 47 cases over the following month. The odds of a continued upward trend are 66%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on DHR as a result. In 57 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
Following a +3.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where DHR advanced for three days, in 174 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
The Aroon Indicator entered an Uptrend today. In 111 of 199 cases where DHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.
Bearish Trend Analysis
The 10-day RSI Indicator for DHR moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 11 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 38%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
DHR broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.082) is normal, around the industry mean (65.617). P/E Ratio (40.869) is within average values for comparable stocks, (2.429). Projected Growth (PEG Ratio) (1.361) is also within normal values, averaging (3.473). Dividend Yield (0.007) settles around the average of (0.002) among similar stocks. P/S Ratio (5.900) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 20 (best 1 - 100 worst), indicating outstanding price growth. DHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
DHR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 18 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 77 | |
PRICE GROWTH RATING 1..100 | 20 | |
P/E GROWTH RATING 1..100 | 55 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BME | DHR | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 84% | 3 days ago 38% |
| Stochastic ODDS (%) | 3 days ago 75% | 3 days ago 60% |
| Momentum ODDS (%) | 3 days ago 72% | 3 days ago 64% |
| MACD ODDS (%) | 3 days ago 79% | 3 days ago 66% |
| TrendWeek ODDS (%) | 3 days ago 79% | 3 days ago 57% |
| TrendMonth ODDS (%) | 3 days ago 80% | 3 days ago 57% |
| Advances ODDS (%) | 5 days ago 79% | 11 days ago 55% |
| Declines ODDS (%) | 3 days ago 77% | 6 days ago 59% |
| BollingerBands ODDS (%) | 3 days ago 81% | 3 days ago 55% |
| Aroon ODDS (%) | 3 days ago 75% | 3 days ago 56% |
Advertisement
BME and
Correlation & Price change
A.I.dvisor tells us that BME and DHR have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BME and DHR's prices will move in lockstep.
| Ticker / NAME | Correlation To BME | 1D Price Change % | ||
|---|---|---|---|---|
| BME | 100% | -0.92% | ||
| DHR - BME | 16% Poorly correlated | +0.33% | ||
| UNH - BME | 12% Poorly correlated | -1.62% | ||
| ABBV - BME | 12% Poorly correlated | +0.16% | ||
| ABT - BME | 10% Poorly correlated | +1.16% | ||
| AMGN - BME | 9% Poorly correlated | -1.79% | ||
More | ||||
DHR and
Correlation & Price change
A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To DHR | 1D Price Change % | ||
|---|---|---|---|---|
| DHR | 100% | +0.33% | ||
| TMO - DHR | 73% Closely correlated | -0.40% | ||
| RGEN - DHR | 68% Closely correlated | -1.00% | ||
| BIO - DHR | 64% Loosely correlated | +1.77% | ||
| A - DHR | 60% Loosely correlated | -0.47% | ||
| BRKR - DHR | 58% Loosely correlated | +0.49% | ||
More | ||||